Logo
x

Search

Subscribe Now

Risdiplam

Chugai Reports NDA Submission of Risdiplam to the MHLW as the First Oral Drug for SMA in Japan

Chugai Reports NDA Submission of Risdiplam to the MHLW as the First Oral Drug for SMA in Japan

  • October 16, 2020
Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

  • September 28, 2020
PTC Reports the EMA's Acceptance of MAA for Evrysdi (risdiplam) to Treat SMA

PTC Reports the EMA's Acceptance of MAA for Evrysdi (risdiplam) to Treat SMA

  • August 18, 2020
Roche's Evrysdi (risdiplam) Receives the US FDA's Approval for SMA in Adults and Children

Roche's Evrysdi (risdiplam) Receives the US FDA's Approval for SMA in Adults and Children

  • August 10, 2020
The US FDA Delays its Decision on Roche's Risdiplam for the Treatment of Spinal Muscular Atrophy

The US FDA Delays its Decision on Roche's Risdiplam for the Treatment of Spinal Muscular Atrophy

  • April 8, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.